ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

IOBT IO Biotech Inc

1.48
-0.05 (-3.27%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
IO Biotech Inc IOBT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.05 -3.27% 1.48 14:00:11
Open Price Low Price High Price Close Price Previous Close
1.53 1.48 1.58 1.48 1.53
more quote information »

Recent News

Date Time Source Heading
25/4/202406:30GLOBEIO Biotech Announces Abstract Accepted for Presentation at..
15/4/202422:30GLOBEIO Biotech Expands Senior Leadership Team to Progress..
10/4/202402:00GLOBEIO Biotech Presents New Data at AACR 2024 Further Supporting..
05/4/202423:30GLOBEIO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business..
12/3/202407:56EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/3/202408:11GLOBEIO Biotech Announces Acceptance of Abstract to be Presented..
06/3/202409:17EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/3/202408:46EDGAR2Form 8-K - Current report
06/3/202408:40GLOBEIO Biotech Announces 2023 Fourth-Quarter and Year-End..
27/2/202408:05GLOBEIO Biotech to Present at 44th Annual Cowen Health Care..
09/1/202400:11EDGAR2Form 8-K - Current report
22/12/202300:30GLOBEIO Biotech Announces First Patient Dosed in Phase 2..
25/11/202309:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202308:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202300:12GLOBEIO Biotech Announces 2023 Third Quarter Results
14/11/202300:10EDGAR2Form 8-K - Current report
14/11/202300:00GLOBEIO Biotech Appoints Helen Collins, MD, to its Board of..
11/11/202300:00GLOBEIO Biotech Completes Enrollment of 380 Patients in Pivotal..
09/11/202308:30GLOBEIO Biotech Announces Participation in Upcoming Investor..
01/11/202323:30GLOBEIO Biotech Presents Three Posters at the Society for..
23/10/202316:00GLOBEEncouraging Preliminary Data from a Phase 2 Trial Evaluating..
04/10/202307:30GLOBEIO Biotech Announces Three Poster Presentations at the..
13/9/202306:06EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
12/9/202322:05GLOBEIO Biotech Announces New Data Related to its IO102-IO103..
11/9/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
08/9/202300:36EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/9/202322:35GLOBEIO Biotech Announces Participation in Upcoming Investor..
31/8/202306:16EDGAR2Form S-3 - Registration statement under Securities Act of..
16/8/202308:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202307:57EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/8/202311:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202322:41EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202322:31EDGAR2Form 8-K - Current report
11/8/202322:30GLOBEIO Biotech Announces 2023 Second Quarter Results
11/8/202322:05GLOBEIO Biotech Appoints Heidi Hunter to its Board of Directors
10/8/202310:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202310:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202322:05GLOBEIO Biotech Announces Abstract Accepted for Poster..
07/8/202322:31EDGAR2Form 8-K - Current report
07/8/202322:30GLOBEIO Biotech, Inc. Announces $75 Million Private Placement..
28/7/202322:05GLOBEIO Biotech Announces First Patient Dosed in..
26/7/202306:05GLOBEIO Biotech Announces Abstract Accepted for Mini Oral..
20/7/202306:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/7/202306:10EDGAR2Form 3 - Initial statement of beneficial ownership of..
19/7/202306:05EDGAR2Form 8-K - Current report
19/7/202306:05GLOBEIO Biotech Strengthens Executive Management and US Presence..
14/6/202322:00GLOBEIO Biotech Announces Achievement of Significant Phase 3..
01/6/202322:30GLOBEIO Biotech Appoints Christine Richter, Ph.D., MBA, as Senior..

Your Recent History

Delayed Upgrade Clock